# VitaTech S.A

> VitaTech S.A is a VC fund backing Biotechnology, Medical Device and Therapeutics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Jun 2019
- Lead investor: 100%
- Last updated: Aug 2026

VitaTech S.A is a VC fund focused on Biotechnology and Medical Device. VitaTech S.A

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| Medical Device | 2 | 50% |
| Therapeutics | 1 | 25% |
| Pharmaceutical | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 2 | 50% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aesyra | Aesyra develops and commercializes intra-oral sensors that help dental professionals in reducing damages induced on dental prostheses by occlusal problems. |  | Series A | Jun 25, 2019 |  |
| Industrie Biomediche Insubri | Industrie Biomediche Insubri is dedicated to events, support & training.SmartBone is an innovative bone substitute specifically developed for bone regeneration in oral and maxillofacial reconstructive surgery, produced by the swiss company IBI SA. |  | Series A | May 31, 2019 |  |
| Gain Therapeutics | Gain Therapeutics is a developer of pharmacological chaperones drugs designed to treat rare metabolic disorders. The company's drugs utilize Minoryx Direct Enzyme Therapy to identify a new generation of uncomplicated adjuvants, enabling clients to help patients stabilize misfolding mutations and restore protein's enzymatic activity. Ittargets lysosomal enzymes to develop innovative drugs for rare pediatric genetic disorders and selected CNS diseases with high unmet medical needs.Established in 2017 and is headquartered in Bethesda, MD, USA. | $2.7M | Series A | Feb 19, 2019 |  |
| Aesyra | Aesyra develops and commercializes intra-oral sensors that help dental professionals in reducing damages induced on dental prostheses by occlusal problems. |  | Seed |  |  |

4 of 4 investments shown.

## Co-investors
- [TiVentures](https://shizune.co/investors/profile/tiventure) — VC Fund, 2 deals together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Switzerland](https://shizune.co/investors/medical-device-investors-switzerland)

## FAQ

### What does VitaTech S.A invest in?

VitaTech S.A invests primarily in Biotechnology, Medical Device and Therapeutics startups, most often at Series A stage. Most of the 4 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did VitaTech S.A last invest?

The most recent investment recorded for VitaTech S.A closed in Jun 2019. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co